HALB logo

Halberd Corporation Stock Price

OTCPK:HALB Community·US$1.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

HALB Share Price Performance

US$0.0018
-0.00 (-56.25%)
US$0.0018
-0.00 (-56.25%)
Price US$0.0018

HALB Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Halberd Corporation Key Details

US$6.9k

Revenue

US$2.4k

Cost of Revenue

US$4.5k

Gross Profit

US$1.7m

Other Expenses

-US$1.7m

Earnings

Last Reported Earnings
Apr 30, 2022
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About HALB

Founded
2009
Employees
n/a
CEO
William Hartman
WebsiteView website
halberdcorporation.com

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer’s and Parkinson’s disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Recent HALB News & Updates

Recent updates

No updates